Ultrastructural studies of peripheral blood of neonates with Down's syndrome and transient abnormal myelopoiesis.
Ultrastructural studies were performed on blood samples from five neonates with Down's syndrome and transient abnormal myelopoiesis (TAM). Three methods of fixation were employed to detect diaminobenzidine (DAB) reactivity. The first method used glutaraldehyde solution, while the second and third methods used tannic acid-glutaraldehyde mixtures. Before fixation by the second method, specimens were washed in order to eliminate plasma, and before fixation by the third were diluted to lessen the effects of plasma protein. The latter two methods were more sensitive than the first for detection of DAB reactivity, while the third also resulted in better preservation of morphology than did the second. Even the first method was able to detect DAB reactivity in cells of megakaryocyte-platelet series in appropriate sections. Although the majority of blasts appeared with light microscopy to be undifferentiated, their ultrastructural morphology and ultrastructural cytochemistry were in fact found to be quite heterogeneous, consisting of cells of the megakaryocyte-platelet and granulocytic series, including basophils, and erythroid precursors. This finding supported the view that TAM was the result of unstable hematopoiesis rather than true leukemia.
Bessho
F
F
Department of Pediatrics, University of Tokyo Hospital, Japan.
Hayashi
Y
Y
Hayashi
Y
Y
Ohga
K
K
D015100:3,3'-Diaminobenzidine; D001773:Blood Cells / Q000473:pathology / Q000648:ultrastructure*; D001855:Bone Marrow Diseases / Q000097:blood* / Q000150:complications; D002467:Cell Nucleus / Q000473:pathology; D004314:Down Syndrome / Q000097:blood* / Q000150:complications; D005260:Female; D005404:Fixatives; D006412:Hematopoietic Stem Cells / Q000648:ultrastructure; D006801:Humans; D007231:Infant, Newborn; D008297:Male
D005404:Fixatives; D015100:3,3'-Diaminobenzidine